BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khosla J, Yeh AC, Spitzer TR, Dey BR. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies. Bone Marrow Transplant 2018;53:129-37. [DOI: 10.1038/bmt.2017.207] [Cited by in Crossref: 67] [Cited by in F6Publishing: 69] [Article Influence: 11.2] [Reference Citation Analysis]
Number Citing Articles
1 Menezes MDM, Marques AI, Chuva T, Pinho Vaz C, Ferreira H, Branca R, Paiva A, Campos A, Maximino Costa J. Acute kidney injury after allogeneic hematopoietic stem cell transplantation – Predictors and survival impact: A single center retrospective study. Nefrología (English Edition) 2022. [DOI: 10.1016/j.nefroe.2022.11.006] [Reference Citation Analysis]
2 Kebede SS, Yalew A, Yesuf T, Melku M, Bambo GM, Woldu B. The magnitude and associated factors of immune hemolytic anemia among human immuno deficiency virus infected adults attending University of Gondar comprehensive specialized hospital north west Ethiopia 2021 GC, cross sectional study design. PLoS One 2022;17:e0274464. [PMID: 36201533 DOI: 10.1371/journal.pone.0274464] [Reference Citation Analysis]
3 Chan WYK, Ma ALT, Chan EYH, Kan ANC, Ng WF, Lee PPW, Cheuk DKL, Chiang AKS, Leung W, Chan GCF. Epidemiology and outcomes of pediatric transplant-associated thrombotic microangiopathy in Hong Kong. Pediatr Transplant 2022;:e14366. [PMID: 35860972 DOI: 10.1111/petr.14366] [Reference Citation Analysis]
4 Higham CS, Shimano KA, Melton A, Kharbanda S, Chu J, Dara J, Winestone LE, Hermiston ML, Huang JN, Dvorak CC. A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patients. Pediatr Blood Cancer 2022;69:e29641. [PMID: 35253361 DOI: 10.1002/pbc.29641] [Reference Citation Analysis]
5 Abou‐ismail MY, Kapoor S, Citla Sridhar D, Nayak L, Ahuja S. Thrombotic microangiopathies: An illustrated review. Res Pract Thromb Haemost 2022;6. [DOI: 10.1002/rth2.12708] [Reference Citation Analysis]
6 Zhang Z, Wang H, Qi J, Tang Y, Cai C, Zhou M, Pan T, Wu D, Han Y. Acute graft-versus-host disease increase risk and accuracy in prediction model of transplantation-associated thrombotic microangiopathy in patients with myelodysplastic syndrome. Ann Hematol 2022. [PMID: 35357522 DOI: 10.1007/s00277-022-04820-z] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Agarwal S, Cortes-santiago N, Scheurer ME, Bhar S, Mcgovern SL, Martinez C, Sartain SE. Diffuse alveolar hemorrhage: An underreported complication of transplant associated thrombotic microangiopathy. Bone Marrow Transplant. [DOI: 10.1038/s41409-022-01644-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Abudayyeh A, Wanchoo R. Kidney Disease Following Hematopoietic Stem Cell Transplantation. Adv Chronic Kidney Dis 2022;29:103-115.e1. [PMID: 35817518 DOI: 10.1053/j.ackd.2021.11.003] [Reference Citation Analysis]
9 Dulmovits BM, Wolfe LC. Hematologic manifestations of systemic illness. Lanzkowsky's Manual of Pediatric Hematology and Oncology 2022. [DOI: 10.1016/b978-0-12-821671-2.00022-2] [Reference Citation Analysis]
10 张 赵. Clinical Study of Transplant-Associated Thrombotic Microangiopathy. ACM 2022;12:10863-10869. [DOI: 10.12677/acm.2022.12111564] [Reference Citation Analysis]
11 Lee EQ. Neurological complications of hematopoietic stem cell transplantation. Neurological Complications of Systemic Cancer and Antineoplastic Therapy 2022. [DOI: 10.1016/b978-0-12-821976-8.00018-9] [Reference Citation Analysis]
12 Rodrigues EM, Ardissino G, Pintarelli G, Capone V, Mariotti J, Verna M, Bernardo ME, Faraci M, Tozzi M, Bucalossi A, Schiavello E, Biassoni V, Guidetti A, Carotti A, Facchini L, Terruzzi E, Giglio F, Zecca M, Onida F, Caroti L, Cesaro S, Consonni D, Cugno M, Porcaro L. Gene Abnormalities in Transplant Associated-Thrombotic Microangiopathy: Comparison between Recipient and Donor's DNA. Thromb Haemost 2021. [PMID: 34965590 DOI: 10.1055/s-0041-1740498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 de Azevedo JTC, Costa TCM, Lima KC, Maciel TT, Palma PVB, Darrigo-Júnior LG, Setanni Grecco CE, Stracieri ABPL, Elias JB, Pieroni F, Guerino-Cunha RL, Pinto ACS, De Santis GC, Covas DT, Hermine O, Simões BP, Oliveira MC, Malmegrim KCR. Long-Term Effects of Allogeneic Hematopoietic Stem Cell Transplantation on Systemic Inflammation in Sickle Cell Disease Patients. Front Immunol 2021;12:774442. [PMID: 34956203 DOI: 10.3389/fimmu.2021.774442] [Reference Citation Analysis]
14 Gavriilaki E, Ho VT, Schwaeble W, Dudler T, Daha M, Fujita T, Jodele S. Role of the lectin pathway of complement in hematopoietic stem cell transplantation-associated endothelial injury and thrombotic microangiopathy. Exp Hematol Oncol 2021;10:57. [PMID: 34924021 DOI: 10.1186/s40164-021-00249-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Elbahlawan L, McArthur J, Morin CE, Abdelhafeez H, McCarville MB, Ruiz RE, Srinivasan S, Qudeimat A. Pulmonary Complications in Children Following Hematopoietic Cell Transplantation: A Case Report and Review of the Diagnostic Approach. Front Oncol 2021;11:772411. [PMID: 34820335 DOI: 10.3389/fonc.2021.772411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Alhomoud M, Williams A, Magro C, Van Besien K, Vesole DH, Laurence J. Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults. Leuk Lymphoma 2021;:1-5. [PMID: 34668824 DOI: 10.1080/10428194.2021.1992625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sharif MO, Leavis HL, van Paassen P, van Rhenen A, Timmermans SAMEG, Ton E, Laar JMV, Spierings J. Severe thrombotic microangiopathy after autologous stem cell transplantation in systemic sclerosis: a case report. Rheumatology (Oxford) 2021;60:e326-8. [PMID: 33711097 DOI: 10.1093/rheumatology/keab239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Menezes MDM, Marques AI, Chuva T, Pinho Vaz C, Ferreira H, Branca R, Paiva A, Campos A, Maximino Costa J. Acute kidney injury after allogeneic hematopoietic stem cell transplantation – Predictors and survival impact: A single center retrospective study. Nefrología 2021. [DOI: 10.1016/j.nefro.2021.06.010] [Reference Citation Analysis]
19 Thoreau B, von Tokarski F, Bauvois A, Bayer G, Barbet C, Cloarec S, Mérieau E, Lachot S, Garot D, Bernard L, Gyan E, Perrotin F, Pouplard C, Maillot F, Gatault P, Sautenet B, Rusch E, Frémeaux-Bacchi V, Vigneau C, Fakhouri F, Halimi JM. Infection in Patients with Suspected Thrombotic Microangiopathy Based on Clinical Presentation. Clin J Am Soc Nephrol 2021;16:1355-64. [PMID: 34497111 DOI: 10.2215/CJN.17511120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Yang LP, Liu X, Zhang XH. [Advances in the diagnosis and management of transplant-associated thrombotic microangiopathy]. Zhonghua Xue Ye Xue Za Zhi 2021;42:693-9. [PMID: 34547882 DOI: 10.3760/cma.j.issn.0253-2727.2021.08.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Eftychidis I, Sakellari I, Anagnostopoulos A, Gavriilaki E. Endothelial dysfunction and vascular complications after allogeneic hematopoietic cell transplantation: an expert analysis. Expert Rev Hematol 2021. [PMID: 34388057 DOI: 10.1080/17474086.2021.1968823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Wang Z, Zhao M, Gao S. Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation. Front Neurol 2021;12:675756. [PMID: 34335446 DOI: 10.3389/fneur.2021.675756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Higham CS, Collins G, Shimano KA, Melton A, Kharbanda S, Winestone LE, Huang JN, Dara J, Long-Boyle JR, Dvorak CC. Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis. Blood Adv 2021;5:2106-14. [PMID: 33877298 DOI: 10.1182/bloodadvances.2020003988] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Hematopoietic Stem Cell Application Group, Chinese Society of Hematology, Chinese Medical Association. [Chinese consensus on the diagnosis and management of transplant-associated thrombotic microangiopathy (2021)]. Zhonghua Xue Ye Xue Za Zhi 2021;42:177-84. [PMID: 33910301 DOI: 10.3760/cma.j.issn.0253-2727.2021.03.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Lia G, Giaccone L, Leone S, Bruno B. Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role? Front Immunol 2021;12:641427. [PMID: 34093530 DOI: 10.3389/fimmu.2021.641427] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Young JA, Pallas CR, Knovich MA. Transplant-associated thrombotic microangiopathy: theoretical considerations and a practical approach to an unrefined diagnosis. Bone Marrow Transplant 2021;56:1805-17. [PMID: 33875812 DOI: 10.1038/s41409-021-01283-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
27 Baur K, Buser AS, Infanti L, Halter JP, Passweg JR, Holbro A. Immune cytopenia after allogeneic haematopoietic stem-cell transplantation: challenges, approaches, and future directions. Lancet Haematol 2021;8:e229-39. [PMID: 33636143 DOI: 10.1016/S2352-3026(20)30404-X] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Tanizawa N, Koh H, Okamura H, Yamamoto K, Makuuchi Y, Kuno M, Takakuwa T, Koh S, Nanno S, Nishimoto M, Hirose A, Nakamae M, Nakashima Y, Nakane T, Hino M, Nakamae H. Risk Factor and Long-Term Outcome Analyses for Acute Limbic Encephalitis and Calcineurin Inhibitor-Induced Encephalopathy in Adults following Allogeneic Hematopoietic Cell Transplantation. Transplant Cell Ther 2021;27:437.e1-9. [PMID: 33965190 DOI: 10.1016/j.jtct.2021.01.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Rassner M, Baur R, Wäsch R, Schiffer M, Schneider J, Mackensen A, Engelhardt M. Two cases of carfilzomib-induced thrombotic microangiopathy successfully treated with Eculizumab in multiple myeloma. BMC Nephrol 2021;22:32. [PMID: 33461512 DOI: 10.1186/s12882-020-02226-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
30 Deloughery TG. Bleeding and Thrombosis. Oncologic Emergency Medicine 2021. [DOI: 10.1007/978-3-030-67123-5_37] [Reference Citation Analysis]
31 Ikezoe T. SOS/TA-TMA. Japanese Journal of Transplantation and Cellular Therapy 2021;10:136-144. [DOI: 10.7889/tct-21-008] [Reference Citation Analysis]
32 Neri JR, Bezerra ML, Alves LC, Tabosa RA, Dantas SL, da Rocha TJ, Nigri FM, Lima DL. Oral Conditions of Elders and Middle-aged Individuals with Multiple Myeloma. The Journal of Contemporary Dental Practice 2021;22:610-4. [DOI: 10.5005/jp-journals-10024-3108] [Reference Citation Analysis]
33 Mirgh S, Khattry N. Acute Complications in Stem Cell Transplantation. Contemporary Bone Marrow Transplantation 2021. [DOI: 10.1007/978-3-030-36358-1_6] [Reference Citation Analysis]
34 Gkrouzman E, Smith MH, Ghosh N, Laurence JC, Seshan SV, Vaughn JL, Levine AB, Bass AR, Erkan D. Recurrent Complement-Mediated Thrombotic Microangiopathy in a Patient with Systemic Lupus Erythematosus: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery. HSS J 2020;16:507-14. [PMID: 33380989 DOI: 10.1007/s11420-020-09761-9] [Reference Citation Analysis]
35 Van de Louw A, Cohrs A, Leslie D. Clinical Features and Outcome of Thrombotic Microangiopathies: Comparison between Patients with and without Malignancy. Thromb Haemost 2021;121:565-72. [PMID: 33186993 DOI: 10.1055/s-0040-1720974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
36 Machneva EB, Bolokhonova MA, Aliev TZ, Shevtsov DV, Suleymanova AM, Sidorova NV, Osmanov EA, Kirgizov KI. Thrombotic microangiopathy associated with hematopoietic stem cell transplantation: general characteristics and an example from clinical practice. Ross ž det gematol onkol 2020;7:86-93. [DOI: 10.21682/2311-1267-2020-7-3-86-93] [Reference Citation Analysis]
37 Watanabe-Kusunoki K, Nakazawa D, Ishizu A, Atsumi T. Thrombomodulin as a Physiological Modulator of Intravascular Injury. Front Immunol 2020;11:575890. [PMID: 33042158 DOI: 10.3389/fimmu.2020.575890] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
38 Ikezoe T. Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies. Int J Hematol 2021;113:34-44. [PMID: 32902759 DOI: 10.1007/s12185-020-02992-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
39 Sagou K, Fukushima N, Ukai S, Goto M, Ozeki K, Kohno A. Clinical usefulness of diagnostic criteria for transplant-associated thrombotic microangiopathy. Int J Hematol 2020;112:697-706. [DOI: 10.1007/s12185-020-02963-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Sasaki K, Honda A, Shinozaki-Ushiku A, Fujioka Y, Maki H, Toyama K, Ushiku T, Kurokawa M. A case of transplantation-associated thrombotic microangiopathy with autopsy-proven fatal myocardial ischemia after allogeneic hematopoietic stem cell transplantation. Ann Hematol 2021;100:1621-2. [PMID: 32372148 DOI: 10.1007/s00277-020-04027-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Laberko A, Aksenova M, Shipitsina I, Khamin I, Shcherbina A, Balashov D, Maschan A. Serious Hemorrhagic Complications After Successful Treatment of Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy With Defibrotide in Pediatric Patient With Myelodysplastic Syndrome. Front Pediatr 2020;8:155. [PMID: 32432059 DOI: 10.3389/fped.2020.00155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
42 Hildebrandt GC, Chao N. Endothelial cell function and endothelial-related disorders following haematopoietic cell transplantation. Br J Haematol 2020;190:508-19. [PMID: 32319084 DOI: 10.1111/bjh.16621] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
43 Ehmann MA, Medinger M, Bodenmann B, Kraft S, Bollinger N, Heim D, Lengerke C, Tsakiris DA, Passweg J, Tzankov A, Menter T. Histologic features of hematopoietic stem cell transplant-associated thrombotic microangiopathy are best percepted in deep skin biopsies and renal biopsies, while showing a significant overlap with changes related to severe acute graft-versus-host disease in gastrointestinal biopsies. Bone Marrow Transplant 2020;55:1847-50. [PMID: 32231248 DOI: 10.1038/s41409-020-0880-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
44 Scordo M, Giralt S. Compliments to complement blockade for TA-TMA. Blood 2020;135:981-3. [PMID: 32219351 DOI: 10.1182/blood.2020005040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
45 Scordo M, Giralt SA. A key step towards setting a benchmark for tackling transplant‐associated thrombotic microangiopathy. Br J Haematol 2020;189:1006-9. [DOI: 10.1111/bjh.16507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Dreger P, Fenske TS, Montoto S, Pasquini MC, Sureda A, Hamadani M; European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Research (CIBMTR). Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation? Biol Blood Marrow Transplant 2020;26:e77-85. [PMID: 31917272 DOI: 10.1016/j.bbmt.2019.12.771] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
47 Temiz G, Kemmner S, Heemann U. Graft-versus-host disease. Onco-Nephrology 2020. [DOI: 10.1016/b978-0-323-54945-5.00023-0] [Reference Citation Analysis]
48 Joseph C, Angelo JR, Laskin BL, Hingorani S. Hematopoietic cell transplant associated kidney injury. Onco-Nephrology 2020. [DOI: 10.1016/b978-0-323-54945-5.00020-5] [Reference Citation Analysis]
49 Ikeda M, Nishikawa T, Abematsu T, Kawamura J, Yokoyama S, Hirai K, Miyahara E, Shigemi A, Ikawa K, Okamoto Y, Migita M, Kawano Y. Pulmonary arterial hypertension and transplant-associated thrombotic microangiopathy in a child with neuroblastoma after autologous peripheral blood stem cell transplantation. Journal of Hematopoietic Cell Transplantation 2020;9:60-64. [DOI: 10.7889/hct-19-009] [Reference Citation Analysis]
50 Mirgh S, Khattry N. Acute Complications in Stem Cell Transplantation. Contemporary Bone Marrow Transplantation 2020. [DOI: 10.1007/978-3-319-64938-2_6-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Karakioulaki M, Martinez M, Medinger M, Heim D, Passweg JR, Tsakiris DA. Peripheral blood schistocytes in the acute phase after allogeneic or autologous stem cell transplantation assessed by digital microscopy. Int J Lab Hem 2019;42:145-51. [DOI: 10.1111/ijlh.13130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
52 Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, Pham HP, Schneiderman J, Witt V, Wu Y, Zantek ND, Dunbar NM, Schwartz GEJ. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue. J Clin Apher. 2019;34:171-354. [PMID: 31180581 DOI: 10.1002/jca.21705] [Cited by in Crossref: 539] [Cited by in F6Publishing: 565] [Article Influence: 134.8] [Reference Citation Analysis]
53 Tolbert VP, Dvorak CC, Golden C, Vissa M, El-haj N, Perwad F, Matthay KK, Vo KT. Risk Factors for Transplant-Associated Thrombotic Microangiopathy after Autologous Hematopoietic Cell Transplant in High-Risk Neuroblastoma. Biology of Blood and Marrow Transplantation 2019;25:2031-9. [DOI: 10.1016/j.bbmt.2019.06.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
54 Portuguese AJ, Gleber C, Passero FC, Lipe B. A review of thrombotic microangiopathies in multiple myeloma. Leukemia Research 2019;85:106195. [DOI: 10.1016/j.leukres.2019.106195] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
55 Thomas MR, Scully M. Microangiopathy in Cancer: Causes, Consequences, and Management. In: Soff G, editor. Thrombosis and Hemostasis in Cancer. Cham: Springer International Publishing; 2019. pp. 151-8. [DOI: 10.1007/978-3-030-20315-3_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
56 Detrait M, de Berranger E, Dulery R, Ménard AL, Thépot S, Toprak SK, Turlure P, Yakoub-Agha I, Guillaume T. [Renal failure after allogeneic hematopoietic stem cell transplantation: Recommendations of the Francophone Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)]. Bull Cancer 2020;107:S28-35. [PMID: 31303250 DOI: 10.1016/j.bulcan.2019.05.002] [Reference Citation Analysis]
57 Elemary M, Sabry W, Seghatchian J, Goubran H. Transplant-associated thrombotic microangiopathy: Diagnostic challenges and management strategies. Transfusion and Apheresis Science 2019;58:347-50. [DOI: 10.1016/j.transci.2019.04.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
58 Dvorak CC, Higham C, Shimano KA. Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management. Front Pediatr 2019;7:133. [PMID: 31024873 DOI: 10.3389/fped.2019.00133] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 11.3] [Reference Citation Analysis]
59 Carreras E, Diaz-ricart M. Early Complications of Endothelial Origin. The EBMT Handbook 2019. [DOI: 10.1007/978-3-030-02278-5_42] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
60 Schuh MP, Bennett MR, Lane A, Jodele S, Laskin BL, Devarajan P. Haptoglobin degradation product as a novel serum biomarker for hematopoietic stem cell transplant-associated thrombotic microangiopathy. Pediatr Nephrol 2019;34:865-71. [PMID: 30569313 DOI: 10.1007/s00467-018-4178-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
61 Bondeelle L, Bergeron A. Managing pulmonary complications in allogeneic hematopoietic stem cell transplantation. Expert Rev Respir Med 2019;13:105-19. [PMID: 30523731 DOI: 10.1080/17476348.2019.1557049] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
62 Kraft S, Bollinger N, Bodenmann B, Heim D, Bucher C, Lengerke C, Kleber M, Tsakiris DA, Passweg J, Tzankov A, Medinger M. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease. Bone Marrow Transplant 2019;54:540-8. [DOI: 10.1038/s41409-018-0293-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
63 Yanir AD, Martinez CA, Sasa G, Leung K, Gottschalk S, Omer B, Ahmed N, Hegde M, Eunji J, Liu H, Heslop HE, Brenner MK, Krance RA, Naik S. Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives—A Single-Center Experience, 2008 to 2016. Biology of Blood and Marrow Transplantation 2018;24:1424-31. [DOI: 10.1016/j.bbmt.2018.03.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
64 Ikeda K, Ohto H, Okuyama Y, Yamada-fujiwara M, Kanamori H, Fujiwara S, Muroi K, Mori T, Kasama K, Iseki T, Nagamura-inoue T, Fujii N, Ashida T, Kameda K, Kanda J, Hirose A, Takahashi T, Nagai K, Minakawa K, Tanosaki R. Adverse Events Associated With Infusion of Hematopoietic Stem Cell Products: A Prospective and Multicenter Surveillance Study. Transfusion Medicine Reviews 2018;32:186-94. [DOI: 10.1016/j.tmrv.2018.05.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
65 Gomes AOF, Silva Junior A, Noce CW, Ferreira M, Maiolino A, Torres SR. The frequency of oral conditions detected in hematology inpatients. Hematol Transfus Cell Ther 2018;40:240-4. [PMID: 30128432 DOI: 10.1016/j.htct.2018.02.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
66 Gale M, Dhawan V, Pastores SM. Hematologic Challenges in ICU Patients with Malignancy. Hematologic Challenges in the Critically Ill 2018. [DOI: 10.1007/978-3-319-93572-0_12] [Reference Citation Analysis]